These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4007774)

  • 1. Elevation of high density lipoproteins in acromegalics after lisuride treatment.
    Hainer V; Zák A; Sindelková E; Wernischová V; Bĕlikovová H; Skorepa J
    Horm Metab Res; 1985 Apr; 17(4):220-1. PubMed ID: 4007774
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hyperprolactinemia and acromegaly with lisuride].
    Berezin M; Elchalal U; Olchovsky D
    Harefuah; 1989 Jun; 116(12):634-7. PubMed ID: 2792946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of growth hormone response to thyreoliberin in the evaluation of lisuride therapy of acromegaly].
    Felt V; Nedvídková J
    Vnitr Lek; 1982 Aug; 28(8):756-61. PubMed ID: 6814061
    [No Abstract]   [Full Text] [Related]  

  • 4. [Terguride in the treatment of hyperprolactinemia and acromegaly].
    Marek J; Bauer J; Srámková J; Hána V
    Cas Lek Cesk; 1986 Jan; 125(4):100-5. PubMed ID: 3948223
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
    Felt V; Nedvídková J
    Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term treatment of acromegaly with lisuride: differences of effect on growth hormone and somatomedin.
    Marek J; Srámková J; Schüllerová M; Stĕpán J; Schreiberová O
    Endokrinologie; 1981 Dec; 78(2-3):175-85. PubMed ID: 7037372
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of dironyl in the treatment of acromegaly and hyperprolactinemia].
    Felt V; Nedvídková J
    Vnitr Lek; 1985 Oct; 31(10):980-5. PubMed ID: 4090298
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug therapy of hyperprolactinemia, acromegaly and Cushing syndrome].
    Marek J; Rezábek K; Srámková J
    Z Gesamte Inn Med; 1983 Nov; 38(22):246-8. PubMed ID: 6666180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of lysenyl-forte treatment in acromegaly and hyperprolactinemia syndrome].
    Balabolkin MI; Gerasimov GA; Snigireva RIa; Gorokhova TR
    Klin Med (Mosk); 1989 Sep; 67(9):89-92. PubMed ID: 2586051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion of free catecholamines in long-term treatment with dopaminergic agonists.
    Marek J; Kopecká J
    Exp Clin Endocrinol; 1984 Oct; 84(2):183-90. PubMed ID: 6151906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fall of the growth hormone levels in acromegalics after bromocryptin (author's transl)].
    Dolecek R
    Cas Lek Cesk; 1976 Aug; 115(33-34):1056-7. PubMed ID: 989744
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contribution to the treatment of headache with lisuride].
    Lazzaroni A; Savonelli C; Bianchi MG; Mallucci C; Maggi GC
    Clin Ter; 1984 Jun; 109(5):433-9. PubMed ID: 6236934
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lisuride in the treatment of Parkinson syndrome].
    Filipová M; Roth B; Kás S; Macek Z; Rozsíval V; Karen P; Votavová M; Krejcová H
    Cesk Neurol Neurochir; 1987 Mar; 50(2):102-7. PubMed ID: 3581244
    [No Abstract]   [Full Text] [Related]  

  • 14. Lisuride in the treatment of myoclonus.
    Obeso JA; Rothwell JC; Quinn NP; Lang AE; Artieda J; Marsden CD
    Adv Neurol; 1986; 43():191-6. PubMed ID: 3946110
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lisuride in Parkinson disease].
    Leiguarda R; Micheli F; Fernández Pardal M
    Medicina (B Aires); 1985; 45(1):29-34. PubMed ID: 3880105
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of lisuride in severe Parkinson's disease.
    Chin D; Yu YL; Huang CY
    Clin Exp Neurol; 1986; 22():63-9. PubMed ID: 3581512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral administration of lisuride in Parkinson's disease.
    Luquin MR; Obeso JA; Martínez-Lage JM; Tresguerres J; Parada J; Nieuweboer B; Dorow R; Horowski R
    Adv Neurol; 1987; 45():561-8. PubMed ID: 3825733
    [No Abstract]   [Full Text] [Related]  

  • 18. [Analysis of the clinical experience with 136 patients with headache treated with lisuride].
    Gallo MF; Mallucci C; Martelletti P; Romiti A; Vittorini R; Giacovazzo M
    Minerva Med; 1984 Jun; 75(25):1515-8. PubMed ID: 6738903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of lisuride in advanced Parkinson's disease. Potent dopamine and serotonin agonist.
    Lieberman AN; Goldstein M; Neophytides A; Leibowitz M; Gopinathan G; Goodgold A; Pact V; Walker R
    N Y State J Med; 1981 Nov; 81(12):1751-5. PubMed ID: 6949052
    [No Abstract]   [Full Text] [Related]  

  • 20. [Oral lisuride in Parkinson's disease].
    Obeso JA; Luquin MR; Martínez Lage JM
    Med Clin (Barc); 1985 Sep; 85(8):307-12. PubMed ID: 4068822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.